Past cervical intraepithelial neoplasia grade 3, obesity, and earlier menopause are associated with an increased risk of vulval cancer in postmenopausal women
Authors:
Open Access
- 23 June 2016
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 115 (5) , 599-606
Abstract
Vulval cancer predominantly affects postmenopausal women. A smaller proportion of vulval cancers, particularly at older ages, are now thought to be associated with human papillomavirus infection than previously reported, but other risk factors have not been well examined in prospective cohort studies. A total of 1.3 million women aged 49–65 years were followed for incident vulval cancer (ICD-10 C51). Adjusted Cox regression models were used to examine the relationship between reproductive and lifestyle factors and risk of vulval cancer. There were 898 vulval cancers registered in the cohort over an average of 14 years of follow-up; 70% were squamous cell carcinomas. Past registration of cervical carcinoma in situ (RR 2.68; 95% CI 1.71–4.18; PPP<0.001) were associated with a significantly increased risk of subsequent vulval cancer. Past cervical pre-cancer, obesity, and earlier age at menopause are associated with an increased risk of vulval cancer at older ages.Keywords
This publication has 22 references indexed in Scilit:
- Persistent effects of women’s parity and breastfeeding patterns on their body mass index: results from the Million Women StudyInternational Journal of Obesity, 2012
- High prevalence of HPV in non-cervical sites of women with abnormal cervical cytologyBMC Cancer, 2011
- The Etiologic Role of HPV in Vulvar Squamous Cell Carcinoma Fine TunedCancer Epidemiology, Biomarkers & Prevention, 2009
- Risk factors for invasive squamous cell carcinoma of the vulva and vagina—Population‐based case–control study in DenmarkInternational Journal of Cancer, 2008
- Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort studyBMJ, 2005
- Breast cancer and hormone-replacement therapy: the Million Women StudyThe Lancet, 2003
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnessesJournal of Epidemiology and Biostatistics, 2001
- Determinants of Invasive Vulvar Cancer Risk: An Italian Case-Control StudyGynecologic Oncology, 1993
- DeprivationJournal of Social Policy, 1987